Table 2.
Means (SDs) and effect sizes for clinical outcomes for ITT and Protocol Completer sample
| Intent to treat (n = 11) | NET-Protocol Completers (n = 10) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline (t0) | Post-Treat-ment (t1) | 12-month FU (t2) | Effect sizes (d) | Baseline (t0) | Post-Treat-ment (t1) | 12-month FU (t2) | Effect sizes (d) | |||
| (n = 11) | (n = 10) | (n = 8) | (n = 10) | (n = 10) | (n = 8) | |||||
| Outcome | M (SD) | M (SD) | M (SD) | Pre-Post | Pre-FU | M (SD) | M (SD) | M (SD) | Pre-Post | Pre-FU |
| PTSD | 36.18 (9.45) | 25.00 (13.17) | 17.75 (11.45) | 0.7 | 1.5 | 37.40 (9.01) | 25.00 (13.17) | 17.75 (11.45) | 0.8 | 1.7 |
| Borderline Symptoms | 190.64 (54.40) | 141.90 (89.80) | 118.63 (79.03) | 0.6 | 1.0 | 193.80 (56.26) | 141.90 (89.80) | 118.63 (79.03) | 0.6 | 0.9 |
| Depressive Symptoms | 36.82 (9.45) | 22.10 (15.50) | 18.50 (13.23) | 1.2 | 1.0 | 36.70 (9.96) | 22.10 (15.50) | 18.50 (13.23) | 0.9 | 1.3 |
| Dissociative Symptoms | 26.22 (13.87) | 19.40 (11.04) | 20.78 (14.22) | 0.6 | 0.5 | 26.21 (15.41) | 19.40 (11.04) | 20.78 (14.22) | 0.6 | 0.5 |
| Quality of Life | 30.68 (18.00) | 53.25 (31.21) | 56.25 (25.88) | 0.7 | 1.1 | 22.78 (18.52) | 53.75 (31.21) | 56.25 (27.16) | 0.7 | 1.1 |
Note. Means, standard deviations and effect sizes (Cohen’s d) were calculated using raw data. FU = 12-month follow-up